Sanofi Plans to Spin Off Consumer-Healthcare Business

[ad_1] Sanofi said it plans to spin off its consumer-healthcare unit into a publicly listed entity, making it the latest pharmaceutical giant to sharpen its focus on prescription medicines by…

J&J Prices Consumer Unit IPO at $22 a Share

[ad_1] Share Listen (2 min) [ad_2] Source link

Regeneron and Sanofi Look for Billions From COPD Drug

[ad_1] The companies said Dupixent showed positive results in a late-stage study of current or former smokers with the killer disease. [ad_2] Source link

Diabetes Drug Giant Sanofi Cuts Insulin Prices by Up to 78%

[ad_1] Health Sanofi says it would cap patients’ out-of-pocket costs for Lantus insulin at $35 a month [ad_2] Source link

Eli Lilly’s Insulin Decision Puts Others in Hot Seat

[ad_1] The drugmaker’s plan moves the spotlight to industry middlemen, who face a barrage of investigations. [ad_2] Source link

U.S. Appeals Court Sides With Drugmakers on Discount Program

[ad_1] Business Health Care Health Drugmakers can limit shipments to hospitals and clinics of drugs discounted under federal program, court rules in loss for hospitals [ad_2] Source link

WSJ News Exclusive | J&J Slashes Production of Its Unpopular Covid-19 Shot

[ad_1] After mobilizing to quickly develop and manufacture a Covid-19 vaccine, Johnson & Johnson has vastly scaled back its efforts in producing the shots as it faces slumping demand. The…

WSJ News Exclusive | New Dengue Vaccine Approved in Europe

[ad_1] WSJ News Exclusive Health Vaccine from Japanese drugmaker Takeda will provide an alternative to a Sanofi vaccine that has been dogged by safety issues [ad_2] Source link

GSK, Sanofi Shares Jump After U.S. Judge Dismisses Zantac Lawsuit

[ad_1] Business Health Care Health Tens of thousands of lawsuits alleged that the heartburn treatment could cause cancer [ad_2] Source link